STK11 and lung adenocarcinoma: Consistent with known COSMIC STK11 tumor‐specificity (mutations present in 11% of lung adenocarcinomas but only 1% of ductal carcinomas), relatively high levels of STK11 mutations were observed in lung, but not breast samples.